Skip to main content

Table 1 Tumor maker levels and coagulation tests

From: A case of Trousseau’s syndrome due to intrahepatic cholangiocarcinoma with an extremely high level of CA19-9

[normal range]Pre-operative TMs and CTsTMs and CTs at POW4
CA19-9 (U/mL) [0.0-37.0]>12,00004905.5
CEA (ng/mL) [0.0-5.0]589.66.3
CA125 (U/mL) [0.0-35.0]64.8104.8
CA15-3 (U/mL) [0.0-31.3]95.415.3
SLX (U/mL) [0.0-38.0]33046
D-dimer (mg/mL) [0.0-1.0]6.23.2
FDP (mg/mL) [0.0-4.9]8.56.2
fibrinogen (mg/dL) [200-400]438272
  1. TM tumor maker, CT coagulation test, POW4 postoperative week 4, CA19-9 carbohydrate antigen 19-9, CEA carcinoembryonic antigen, CA125 cancer antigen 125, CA15-3 Cancer antigen 15-3, SLX Sialyl Lewis X, FDP fibrin degradation product